patients with {beta}-thalassemia A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in
Daniele Alberti,Nancy Olivieri,Isabelle Thuret,Herbert Opitz,Catherine Ressayre-Djaffer,Peter Marks,Patricia Giardina,Alexandra Kourakli-Symeonidis,Gritta Janka-Schaub,Thomas Coates,Guillermo Drelichman,Carmelo Magnano,Monica Verissimo,Miranda Athanassiou-Metaxa,Antonis Kattamis,Yurdanur Kilinc,John Porter,Marcello Capra,Renzo Galanello,Maria D Cappellini,Alan Cohen,Antonio Piga,Mohamed Bejaoui,Silverio Perrotta,Leyla Agaoglu msra(2010)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper